05/28/2026
💊On May 14, the DOJ announced that Takeda Pharmaceuticals agreed to pay roughly $13.7 million to settle allegations it violated the False Claims Act and Anti-Kickback Statute by paying kickbacks to healthcare providers to induce prescriptions for Takeda’s Trintellix antidepressant medication.
This case is just the latest in the recent string of sizable False Claims Act settlements involving healthcare kickbacks demonstrating that going after kickbacks remains a top DOJ enforcement priority.
Read more about the case in our blog post:
Takeda Pharmaceuticals agreed to pay roughly $13.7M to settle allegations it violated the False Claims Act and Anti-Kickback Statute.